Clinical Trial Update: Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating vosaroxin with infusional cytarabine for untreated acute myeloid leukemia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Acute Myeloid Leukemia Arising From Myelodysplastic Syndrome
• Acute Myeloid Leukemia with Multilineage Dysplasia
• Myeloid Sarcoma
• Therapy-related Acute Myeloid Leukemia
• Therapy-related Myelodysplastic Syndrome

Drugs mentioned

• Cytarabine (infusional) (cytarabine)
• Vosaroxin (vosaroxin)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2020-06-09